Policy Briefings

ImmuPharma Selects Thermo Fisher as CDMO for Kapiglucagon Program

Mabion Signs ADC Development and Manufacturing Agreement with KriSan Biotech

Cellares Partners with Papillon Therapeutics to Automate PPL-001 Manufacturing

SK pharmteco Supports Genethon Gene Therapy Program Through Phase III Manufacturing

Restore Vision Partners with Forge Biologics to Advance RV-001 Gene Therapy

eXmoor Pharma Advances Evox Gene Editing Platform with Technology Transfer

Lonza Licenses ADC Technology Platform to Engitix for Next-Generation Therapies

WuXi Biologics Reaches 1,000th Molecule Milestone Through Earendil Labs Collaboration

Aptyx Appoints David Price as Chief Executive Officer

Samsung Biologics Launches CHF 1.46 Billion(US$1.84 billion) Tender Offer for PolyPeptide

OXB Signs Gene Therapy Manufacturing Agreement with Plowshare Therapies

Merck Opens €25 Million BioReliance Testing Facility in Germany

Cytovance Biologics Expands Upstream Process Development with Perfusion Capabilities

BriaCell Therapeutics Partners with FUJIFILM Biotechnologies California for Phase 3 Bria-IMT Manufacturing

Insilico Medicine and Bora Pharmaceuticals Form AI-Driven Drug Discovery Alliance

OneSource Specialty Pharma Partners with Formycon to Manufacture Biosimilars

Bora Biologics Expands U.S. Manufacturing Platform with Rockville Site

Charles River Laboratories Partners with Arovella Therapeutics for CAR-iNKT Therapy